Precipitating Factors of Hepatic Encephalopathy



Similar documents
HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS

PRECIPITATING FACTORS OF HEPATIC ENCEPHALOPATHY: EXPERIENCE AT PAKISTAN INSTITUTE OF MEDICAL SCIENCES ISLAMABAD.

Spectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis

Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial

Evaluation and Prognosis of Patients with Cirrhosis

The pathogenesis of hepatic encephalopathy in

Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis

{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis}

Presented by: Jean Yoo-Campbell, Matthew Konerman, Monica Konerman, Jean Yoo Campbell, Christian Gocke, Eunpi Cho Donald Lynch

Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room

Cirrhosis of liver: Etiological factors, complications and prognosis

NUTRITION IN LIVER DISEASES

A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY

Economic Impact of Treatment Options for Hepatic Encephalopathy

Liver Failure. Nora Aziz. Bones, Brains & Blood Vessels

Date of preparation: March GL/XIF/0214/0011a(1)

MANAGEMENT OF LIVER CIRRHOSIS

Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine

Cirrhosis and HCV. Jonathan Israel M.D.

End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012

HEPATOLOGY CLERKSHIP

After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH

Patterns of abnormal LFTs and their differential diagnosis

Living With Hepatic Encephalopathy (HE)

Liver Diseases. An Essential Guide for Nurses and Health Care Professionals

Surveillance for Hepatocellular Carcinoma

DIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY

Results Demographic profile of these children is shown in Table I.

Acute on Chronic Liver Failure: Current Concepts. Disclosures

The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome

Hepatitis Panel/Acute Hepatitis Panel

PREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto

COMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.

NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum

The rate of failure to thrive among children aged 2 months - 5 years in Kanaan sub-district / Diyala province

Approach to Abnormal Liver Tests

Acute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.

PEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW

Hepatic Encephalopathy (Brain Disorder Secondary to Liver Disease) Basics

HEPATIC ENCEPHALOPATHY

Early Liver Transplantation in Patients with Acute Hepatitis

ECG may be indicated for patients with cardiovascular risk factors

CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS

AUBAGIO (teriflunomide) oral tablet

Management of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok

NORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1

The most serious symptoms of this stage are:

Liver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB

The sooner the better

National Health Burden of CLD in Italy

CIRRHOSIS REFERRAL & MANAGEMENT GUIDELINES for the Southern Adelaide Local Health Network (SALHN)

CHOC CHILDREN SUROLOGY CENTER. Constipation

Liver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco

Things You Don t Want to Miss in Multiple Myeloma

Albumin. Prothrombin time. Total protein

Knowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan

How To Know If Low Protein Diet Is Beneficial For Kidney Health

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

INITIATING ORAL AUBAGIO (teriflunomide) THERAPY

UCLA Asian Liver Program

1MFBTF GJMM PVU GPSNT BOE GBY 'PSNT XJMM CF TJHOFE BU ZPVS BQQPJOUNFOU

OMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!

Albumin (serum, plasma)

Science Highlights. To PSA or not to PSA: That is the Question.

How To Determine The Prevalence Of Microalbuminuria

Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During

Efficacy of Rifaximin in Prevention of Recurrence of Hepatic Encephalopathy in Patients with Cirrhosis of Liver

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)

Quality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival

rifaximin 550mg film-coated tablets (Targaxan ) SMC No. (893/13) Norgine Pharmaceuticals Ltd

practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx

Complications of Chronic Liver Disease

Urinary Tract Infection in Stone Patients and in Patients with Indwelling Urethral Catheters

Treatment of Acute Hepatitis C

Omega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9

Life Insurance Application Form

PATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS

June 11, 2015 Tim Halterman

Preoperative Laboratory and Diagnostic Studies

Non-alcoholic fatty liver disease: Prognosis and Treatment

length of stay in hospital, sex, marital status, discharge status and diagnostic categories. Mean age and mean length of stay were compared for the

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

1333 Plaza Blvd, Suite E, Central Point, OR *

Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options?

Transmission of HCV in the United States (CDC estimate)

Transcription:

Original Article Precipitating Factors of Hepatic Encephalopathy Mohammad Tariq,* Saleem Iqbal,** Naji ullah Khan,* Rabia Basri*** From Department of Medicine, Khyber Teaching Hospital, Peshawar. *Post Graduate Trainee, **Senior Registrar, *Post Graduate Trainee, ***House Officer Correspondence: Received: Accepted: Dr. Mohammad Tariq, Medical B Unit, Khyber Teaching Hospital Peshawar, Pakistan. Mob: 0334-9171135 Email: drtariqkhattak@yahoo.com ABSTRACT Objective: To analyze the precipitating factors of hepatic encephalopathy (HE). Methods: Two hundred admitted patients with liver cirrhosis with HE from 1 st January 2006 to 30 th September 2006 were included in the study. Grades of HE and Child s Pugh classification was also determined. Results: Out of 200 patients, 106 (53%) were male and 94 (47%) female. Amongst the precipitating factors, 30% had constipation, 29% upper gastrointestinal bleed (GIB), 8% spontaneous bacterial peritonitis (SBP), 19.5% urinary tract infection (UTI), 2.5% lower respiratory tract infection and 3% had diarrhea. There was hyponatremia in 1.5% and hypokalemia in 4.5% patients. High protein diet in 0.5% and bromazepam intake in 1%

were presumed precipitating factors and 0.5% had antituberculous therapy induced liver injury. Conclusion: Constipation, gastrointestinal bleeding and infections were the most common precipitating factors of HE in our patients. (Rawal Med J 2009;34:95-97). Key Words: Hepatic Encephalopathy, liver cirrhosis, precipitating factors, portosystemic encephalopathy. INTRODUCTION Hepatic encephalopathy (HE) is a neuropsychiatric syndrome, which develops due to acute or chronic liver diseases. It is functional in nature and potentially reversible and symptoms range from subtle personality changes to deep coma. 1 Diminished hepatic reserve results in impaired ability of liver to detoxify toxins that are absorbed from the bowel. 2 Accumulation of ammonia, predominantly as a result of poor hepatic function and portosystemic shunting, has traditionally been considered to have an important role in the pathogenesis of HE. 3 The level of ammonia in the arterial blood, however, is poorly correlated with the grade of HE. 4 Most episodes of HE in patients with cirrhosis are due to clinically apparent precipitating factors or the spontaneous development of portosystemic shunting. 3 These factors could be determined in 75.4% of chronic and 97.3% episodes of acute HE. 5 The frequency of risk factors for the

development of HE in patients with chronic liver disease was 47% due to infections, 30% due to GIT bleeding, 19% due to constipation, and 4% due to miscellaneous factors. 6 The overall in-hospital mortality was 29% 7 and mean time to come out of HE was 41.38 hours. 8 HE has been classified into four grades that range from grade I to IV 9 and identification of precipitating factors is helpful, as the neurological deficits are usually completely reversible upon their correction. 10 The aim of this study was to determine the frequency of precipitating factors for the development of HE in patients admitted with liver cirrhosis at our institution. PATIENTS AND METHODS We conducted a descriptive, cross sectional, prospective, single center study on 200 consecutive patients of HE admitted to the medical units of Khyber Teaching Hospital, Peshawar from 1 st January 2006 to September 2006. All patients who were 15 years or above in age with HE and liver cirrhosis were included. A detailed clinical history and meticulous physical examination of every patient was done. Diagnosis of HE was made on clinical basis. All relevant investigations including full blood count, urine microscopy, serum electrolytes, blood urea, serum creatinine, blood glucose, sonography and a chest radiograph were done. In the presence of ascites a diagnostic ascitic tap was also done to look for any evidence of spontaneous bacterial peritonitis (SBP).

Serum bilirubin, Alanine Aminotransferase (ALT) levels, serum albumin and prothrombin time were also done to help assess their Child-Pugh score. All patients were followed for the duration of their stay in hospital. Data were analyzed using SPSS version 11.0. RESULTS Out of 200 patients, 106 (53%) were males and 94 (47%) were females. Majority of the patients (67%) were in the age group of 41-50 years. Only one (0.5%) was below the age of 20 years (Table 1). Table 1. Age-wise distribution of 200 patients with HE. Age (years) Number of patients Percentage 11-20 1 0.5% 21-30 11 5.5% 31-40 15 7.5% 41-50 67 33.5% 51-60 63 31.5% 61-70 40 20% 71-80 3 1.5% Total 200 100.0% Large percentage had hepatitis C (Fig 1) and majority was in grade I and II HE (Table 2). All patients belonged to Child-Pugh class-b and C (Table 3).

Table 2. Grades of Hepatic Encephalopathy (N = 200). Grade of hepatic Number of patients Percentage encephalopathy Grade I 58 29.0% Grade II 83 41.5% Grade III 38 19.0% Grade IV 21 10.5% Amongst the precipitating factors, constipation, gastrointestinal bleed (GIB) and infections were most commonly encountered (Table 4). Table 3. Child-pugh class of Hepatic Encephalopathy (N = 200). Child-Pugh class Number of patients Percentage A 0 0 B 67 33.5% C 133 66.5% None of the patients had history of alcohol intake, recent surgery or shunt procedure.

Fig 1. Viral status in 200 patients with hepatic encephalopathy. 100 80 60 40 20 Percent 0 Hepatitis B Virus+ Both B&C Positive Both B&C Negative Hepatitis C Virus+ Viral status Out of these 200 patients, 180 (90%) patients recovered from encephalopathy, six (3%) patients left against medical advice (LAMA) and 14 (7%) patients expired.

Table 4. Precipitating factors in 200 patients of Hepatic Encephalopathy and gender of patients (N = 200). Precipitating factor of hepatic encephalopathy Gender of the patients Percent of total patients P value Number of Number of females males Constipation 34 26 30% 0.589 Upper gastrointestinal bleeding 17 41 29% 0.035 Urinary tract infection 19 20 19.5% 0.000 Spontaneous bacterial peritonitis 10 6 8% 0.050 Hypokalemia 4 5 4.5% 0.000 Diarrhea 5 1 3% 0.000 Lower respiratory tract infection 1 4 2.5% 0.000 Hyponatremia 3 0 1.5% 0.000 Sedative intake 0 2 1% 0.286 Excessive protein intake 0 1 0.5% 0.000 Antituberculous therapy induced 1 0 0.5% 0.000 DISCUSSION Cirrhosis of liver is one of the common causes of morbidity and mortality world over. 11 HE is a major neuropsychiatric complication of cirrhosis and it s appearance is indicative of a poor prognosis, 12,13 as HE is the commonest cause of death in patients with liver cirrhosis. 14 A clearly defined precipitating factor is usually identified in most patients with HE, and the reversal or control of these factors is a key step in the management. 15 Our study had more male patients with majority of those 40-60 years old, as reported earlier. Constipation was the commonest factor responsible for 30% cases of HE in our patients, which is close to earlier published studies. 8,15 Constipation probably is the result of lack of consistent use of lactulose by our patients,

he. Precipitating factor of HE which may be because of its cost or patients did not find it a good laxative. Infections like SBP, urinary tract infection and lower respiratory tract infection were the 2 nd most common factor present in 30% of cases, as shown to be 28% in another study. 16 GIB was the third most important factor and was found in 29% of patients in our study, which is similar to 30% 6 and 33% 17 reported earlier. This study correlates well to the available national and international data (Table 5). Table 5. Comparison of frequency of different precipitating factors of Shaikh 18 Ahmed 16 Conn 9 Faloon 17 Alam 15 Mahboob 6 Present Study Constipation 52 52 3 6 32 19 30 Diarrhea 12 22 - - 40 5 3 Gastrointestinal 56 56 18 33 22 30 29 bleed Infections 15 28 4-24 47 30 Hypokalemia 70 68 9 18 18-4.5 Hyponatremia 28 28-36 - 1.5 Increase protein - 52 9-4 1 0.5 intake Sedative intake - - - - - 2 1 Miscellaneous - - - - - 4 0.5 Figures are percentages. Electrolyte imbalance was found in 12 (6%) patients, consistent with study of Conn et al 9 who reported it in 9%. We found diarrhea in 6 (3%), high protein intake in 1 (0.5%) and sedative intake in 2 (1%) patients, which are similar to studies reported already. 6,9 In conclusion, constipation, gastrointestinal bleeding and infections stand out as the most common precipitating factors of HE in almost all the studies. There is a definite need

for health education in patients with cirrhosis regarding the risk of HE and its precipitating factors and a proper dietary advice to them. REFERENCES 1. Haussinger D, Kircheis G. Hepatic encephalopathy. Schweiz Rundsch Med Prax. 2002;91:957-63. 2. Lizardi-Cervera J, Almeda P, Guevara L, Urabe M. Hepatic encephalopathy: a review. Ann Hepatol. 2003;2:122-30. 3. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337:473-9. 4. Blom HJ, Ferenci P, Grimm G, Yap SH, Tangerman A. The role of methanethiol in the pathogenesis of hepatic encephalopathy. Hepatology. 1991;13:445-54. 5. Strauss E, da Costa MF. The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology. 1998;45:900-4. 6. Mahboob F. Frequency of risk factors for hepatic encephalopathy in patients of chronic liver disease. Ann King Edward Med Coll. 2003;9:29-30. 7. Sheikh A, Ahmed SI, Naseemullah M. Aetiology of hepatic encephalopathy and importance of upper gastrointestinal bleeding

and infections as precipitating factors. J Rawal Med Coll. 2001;5:10-2. 8. Khurram M, Khaar HB, Minhas Z, Javed S, Hassan Z, Hameed TA, et al. An experience of cirrhotic hepatic encephalopathy at DHQ Teaching Hospital. J Rawal Med Coll. 2001;5:60-4. 9. Conn HO. Quantifying the severity of hepatic encephalopathy. In: Conn HO, Bircher J, editors. Hepatic encephalopathy: syndromes and therapies. West Lansing, MI: Medi-ed Press; 1993.p.13. 10. Lockwood AH. Early detection of hepatic encephalopathy. Neurology. 1998;6:663-6. 11. Mashud I, Khan H, Khattak AM. Relative frequency of Hepatitis B and C viruses in patients with hepatic cirrhosis at DHQ Teaching Hospital DI Khan. J Ayub Med Coll Abbottabad. 2004;16:32-4. 12. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001:120:170-8. 13. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis. 1978;23:398 406.

14. Alam I, Razaullah, Haider I, Humayun M, Taqweem MA, Nisar M. Spectrum of precipitating factors of hepatic encephalopathy in liver cirrhosis. Pak J Med Res. 2005;44:96-100. 15. Ahmed H, Rehman M, Saeedi MI, Shah D. Factors precipitating hepatic encephalopathy in cirrhosis liver. J Postgrad Med Inst. 2001;151:91-7. 16. Faloon WW, Evans GL. Precipitating factors in the genesis of hepatic coma. NY State J Med. 1970;70:2891-6. 17. Shaikh MA, Shaikh WM, Solangi GA, Abro H. Frequency and transmission mode of Hepatitis C virus in Northern Sindh. J Coll Physician Surg Pak. 2003;13:691-93. 18. Fitz JG. Hepatic encephalopathy, hepatopulmonary syndromes, hepatorenal syndrome, coagulopathy and endocrine complications of liver disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002; 1543-65. 19. Maqsood S, Saleem A, Iqbal A, Butt JA. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute Medical Sciences Islamabad. J Ayub Med Coll Abbottabad. 2006;18:57-61.